Solar photocatalytically active, engineered silver nanoparticle synthesis using aqueous extract of mesocarp of Cocos nucifera (Red Spicata Dwarf)

Silver nanoparticles synthesised using aqueous extract of Cocos nucifera (CN) mesocarp were evaluated for their photocatalytic activity under solar irradiation. The silver nanoparticles were synthesised by a green method of harnessing bioactive phytocomponents from the mesocarp of Cocos nucifera. Large-scale application of this process necessitates the manoeuvering of the process parameters for increasing the conversion of silver ions to nanoparticles. Process parameters influencing the morphological characteristics of silver nanoparticles such as precursor salt concentration and pH of the synthesis mixture were studied. The crystalline nanoparticles were characterised using UV-vis spectroscopy, XRD, FTIR, SEM and EDX analysis. CN extract and 5 mM silver nitrate solution at a ratio of 1:4 (v/v) in the synthesis mixture was found to be the optimum. Alkaline initial pH of the synthesis mixture was found to favour the synthesis of smaller sized monodispersed silver nanoparticles. Solar energy was harnessed for the photocatalytic degradation of Malachite green dye using silver nanoparticles obtained through the green synthesis method. Overall process aims at utilisation of naturally available resource for the synthesis of silver nanoparticles as well as the degradation of dyes using these nanoparticles, making it useful in the treatment of wastewater

Microbial-Assisted Phytoremediation: A Convenient Use of Plant and Microbes to Clean Up Soils

Environmental pollution by metal(loid)s (e.g., heavy metals—HMs) is a severe problem worldwide, as soils and aquatic resources became increasingly contaminated, threatening land ecosystems, surface and groundwater, as well as food safety and human health. The primary sources contributing to this extended pollution are anthropogenic inputs related to the burning of fossil fuels, mining and continued industrial activities, disposal of municipal solid wastes and wastewater discharges or use for irrigation, and excessive utilization of fertilizers and pesticides. A consequence of these anthropogenic activities is an increase of contaminated areas, which should be remediated to prevent or mitigate transfer of contaminants into terrestrial, atmospheric, or aquatic environments. Point and diffuse contamination by organic and inorganic pollutants causes wide concerns, and intentional or accidental introduction of these substances in the environment may represent serious impacts on public health

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN